Post–COVID-19 anxiety and its impact on adults’ health in Qatar in 2022
Qatar Medical Journal · 2026 · 2026 (2)
DOI: 10.5339/qmj.2026.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Qatar Medical Journal, 2026. Verfasst von Nada Adli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Community and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Post–COVID-19 syndrome (PCS) is an emerging public health issue characterized by persistent symptoms, including anxiety. Anxiety is the most frequent mental health persistent symptom among patients with PCS, with global prevalence ranging from 6.5% to 63%. It negatively impacts people’s functioning, productivity, and daily routine beyond recovery. This study aimed to examine the prevalence, determinants, and health impact of anxiety symptoms among adults with post–COVID-19 in Qatar during 2022.
Methods
A cross-sectional study was conducted in Qatar between January and July 2022, utilizing data from the Primary Health Care Corporation’s Business Intelligence Unit. Out of 368 eligible individuals, 159 adults with confirmed PCS lasting more than 12 weeks were randomly selected and interviewed by telephone after providing consent. Anxiety levels were assessed using the Generalized Anxiety Disorder-7 (GAD-7) scale.
Results
Out of 159, the prevalence of anxiety symptoms was 50.3% ( n = 80) based on GAD-7. Most of the participants were female, Qatari, married, and unemployed. Hospitalization and functional impairment were also higher in the anxiety group compared to those without anxiety. Depression, disability, and cognitive dysfunction were strongly associated with the post–COVID-19 anxiety group compared to the non-anxiety group, with P < 0.05.
Conclusion
Post–COVID-19 anxiety is prevalent among PCS patients in Qatar and linked to worse mental and physical health outcomes. Routine screening and integrated care approaches are essential to support recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Community and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
- Community and Preventive Medicine Department, Primary Health Care Corporation (PHCC), Doha, Qatar.
- Community and Preventive Medicine Department, Hamad Medical Corporation, Doha, Qatar.
- Clinical Psychologist, Psychiatry Department, Hamad Medical Corporation, Doha, Qatar.
- University of Doha for Science and Technology, Doha, Qatar.
- Senior Consultant of Community and Preventive Medicine, Primary Health Care Corporation (PHCC), Doha, Qatar.
Zitieren
APA
Adli, N., Bala, M., AlMesbah, N., Ajabein, M., Homaida, M., Abuhashem, M. A., Mohamad, N., Fayyaz, T., Awad, M., Kehyayan, V., Al-Khenji, A. H., Al-Kuwari, M. G., Bougmiza, I., & Selim, N. (2026). Post–COVID-19 anxiety and its impact on adults’ health in Qatar in 2022. Qatar Medical Journal, 2026(2). https://doi.org/10.5339/qmj.2026.23
Vancouver
Adli N, Bala M, AlMesbah N, Ajabein M, Homaida M, Abuhashem MA, et al. Post–COVID-19 anxiety and its impact on adults’ health in Qatar in 2022. Qatar Medical Journal. 2026;2026(2). doi:10.5339/qmj.2026.23
BibTeX
@article{Adli2026,
author = {Adli, Nada and Bala, Mohamed and AlMesbah, Nahlah and Ajabein, Mai and Homaida, Maysa and Abuhashem, Musa Adli and Mohamad, Nada and Fayyaz, Tajala and Awad, Mishkat and Kehyayan, Vahe and Al-Khenji, Abdul Hameed and Al-Kuwari, Mohamed Ghaith and Bougmiza, Iheb and Selim, Nagah},
title = {Post–COVID-19 anxiety and its impact on adults’ health in Qatar in 2022},
journal = {Qatar Medical Journal},
year = {2026},
volume = {2026},
number = {2},
doi = {10.5339/qmj.2026.23}
}
EUVIMED